Advertisement
Screener

Heartflow, Inc. (HTFL) Accretion Expense

2.8 / 5 stars · 68/120 Roast Me

Heartflow, Inc. Accretion Expense

Heartflow, Inc. (HTFL) reported Accretion Expense of $1.07 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AccretionExpense · last filed 2025-11-12

  • Heartflow, Inc. accretion expense for the quarter ending 2025-09-30 was -$39.00K, a 105.50% decline year-over-year.
  • Heartflow, Inc. accretion expense for the quarter ending 2024-09-30 was $709.00K.
Period endAccretion Expense 3 monthAccretion Expense 6 monthAccretion Expense 9 month
2025-09-30-$39.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$1.07M
10-Q · filed 2025-11-12
2025-06-30$1.11M
10-Q · filed 2025-09-19
2024-09-30$709.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$1.10M
10-Q · filed 2025-11-12
2024-06-30$388.00K
10-Q · filed 2025-09-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55